This paper examines the key differences and similarities between Hodgkin's and Non-Hodgkin's Lymphoma, two cancers originating in lymphocytes. It covers how each is diagnosed, the epidemiology of Non-Hodgkin's Lymphoma as one of the most common cancers in the United States, and the major factors that determine prognosis—including patient age, disease stage, organ involvement, performance status, and serum lactate dehydrogenase levels. The paper also outlines the four prognostic risk groups established by the American Cancer Society and concludes that Hodgkin's Lymphoma generally carries a more favorable prognosis than Non-Hodgkin's Lymphoma.
Both Hodgkin's and Non-Hodgkin's Lymphoma are cancers that originate in a type of white blood cell known as a lymphocyte, an important component of the body's immune system (Stippler, 2014). Both malignancies produce similar symptoms; however, Hodgkin's and Non-Hodgkin's Lymphoma are differentiated through "biopsy or aspiration of the tumor tissue" (Stippler, 2014, p. 1). The type of abnormal cells identified in the sample determines whether a lymphoma is classified as Hodgkin's disease or Non-Hodgkin's Lymphoma (Stippler, 2014).
Of the two, Non-Hodgkin's Lymphoma is the more common. In the United States, Non-Hodgkin's Lymphoma is the sixth most common cancer among males and the fifth most common cancer among females. Furthermore, its incidence has been steadily increasing over recent decades. Non-Hodgkin's Lymphoma is a heterogeneous group of over 30 types of cancers, distinguished by differences in the microscopic appearance and biological characterization of the malignant lymphocytes. The different types also vary in their biologic behavior—such as the tendency to grow aggressively—which affects a patient's overall prognosis (Stippler, 2014).
Understanding the distinctions between these two forms of lymphoma is essential for guiding treatment decisions and setting realistic expectations for patient outcomes.
Prognosis for lymphoma is based on the following factors (American Cancer Society, 2015):
According to the American Cancer Society (2015), individuals diagnosed with lymphoma are classified into four prognostic groups based on the number of poor prognostic factors present:
These classifications help clinicians determine the appropriate course of treatment and provide patients with a clearer understanding of their expected outcomes.
When comparing the prognoses of Hodgkin's and Non-Hodgkin's Lymphoma, the prognosis for Hodgkin's Lymphoma is found to have better outcomes overall.
"Four-tier risk group classification system"
Stippler, M. C. (2014). Hodgkin's and non-Hodgkin's lymphoma: Differences and similarities. MedicineNet. Retrieved from
You’re 73% through this paper. Sign up to read the remaining 1 section.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.